Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Common Stock of Cell Pathways Commences on Nasdaq November 4.


HORSHAM Horsham (hôr`shəm), town (1991 pop. 38,356) and district, West Sussex, SE England. Horsham is known primarily for its agricultural and merchandising activities, but it also serves as an engineering center. , Pa.--(BW HealthWire)--Nov. 4, 1998--The Common Stock of Cell Pathways, Inc. (Nasdaq:CLPA CLPA CC-Link Partner Association
CLPA Club Loisirs et Plein Air (Montpellier, France)
CLPA Child Labour Programme of Action (national plan to eliminate child labour in South Africa) 
) commenced trading today, November November: see month.  4, on the Nasdaq National Market under the symbol CLPA.

The previously announced acquisition of Tseng Labs (Tseng Labs, Inc., Newtown, PA) A company that manufactured chipsets and display adapters for PCs. Founded in 1983, it provided products that enhanced PC display standards, and its ET3000 and ET4000 chips have been used in millions of display adapters. , Inc. closed yesterday. As the result of the transaction, each share of Tseng Labs will be exchanged for approximately .36 of a share of Cell Pathways (or approximately 2.75 Tseng shares for one Cell Pathways share). Trading in Tseng Labs ceased at the end of November 3; the closing price was $6.00.

Each stockholder of record of Tseng Labs as of the close of business on November 4 will receive a letter of transmittal Letter of Transmittal

A document used by security holder to accompany certificates surrendered in an exchange or other corporate action.
 from Cell Pathways' transfer agent in order to facilitate the exchange of stock certificates.

Cell Pathways, Inc. is a pharmaceutical company focused on the development and commercialization of products to prevent and treat cancer.

For additional information on Cell Pathways, Inc., visit the company's website at http://www.cellpathways.com.
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 4, 1998
Words:162
Previous Article:Case Corporation Completes Acquisition of DMI, Inc.
Next Article:HMT to Supply Western Digital Corp. with Advanced Magnetoresistive Media for its Newest 18.3GB Enterprise Storage Product.
Topics:



Related Articles
Tseng Stockholders Approve Combination With Cell Pathways.
Law Offices Bernard M. Gross, P.C. Announces Class Action Against Cell Pathways Corporation.
Cell Pathways, Inc. Reports Fourth Quarter and 1998 Financial Results.
Cohen, Milstein, Hausfeld & Toll, P.L.L.C. Files Class Action Suit Against Cell Pathways, Inc.
Attention Cell Pathways CLPA Investors.
REPEAT/Cell Pathways Announces Positive One-Year Data from Extension Trial of Aptosyn --Exisulind-- in FAP Patients; NDA Review Period Extended.
Cell Pathways, Inc. Reports Fourth Quarter and 2000 Financial Results.
Law Firm Kirby McInerney & Squire, LLP Announces Class Action Lawsuit Against Cell Pathways, Inc.
Cell Pathways, Inc. Reports First Quarter 2001 Financial Results.
The fat track: signals between cells keep creatures lean.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles